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Abstract
 
Regulatory CD4
 
 
 
CD25
 
 
 
 T cells (Treg) are mandatory for maintaining immunologic self-
tolerance. We demonstrate that the cell-cell contact–mediated suppression of conventional
CD4
 
 
 
 T cells by human CD25
 
 
 
 Treg cells is fixation resistant, independent from mem-
brane-bound TGF-
 
 
 
 but requires activation and protein synthesis of CD25
 
 
 
 Treg cells. Co-
activation of CD25
 
 
 
 Treg cells with Treg cell–depleted CD4
 
 
 
 T cells results in anergized
CD4
 
 
 
 T cells that in turn inhibit the activation of conventional, freshly isolated CD4
 
 
 
 T
helper (Th) cells. This infectious suppressive activity, transferred from CD25
 
 
 
 Treg cells via
cell contact, is cell contact–independent and partially mediated by soluble transforming
growth factor (TGF)-
 
 
 
. The induction of suppressive properties in conventional CD4
 
 
 
 Th
cells represents a mechanism underlying the phenomenon of infectious tolerance. This ex-
 
plains previously published conflicting data on the role of TGF-
 
 
 
 in CD25
 
 
 
 Treg cell–
induced immunosuppression.
Key words: human regulatory T cells • CD4
 
 
 
CD25
 
 
 
 T cells • infectious tolerance • T cell 
inhibition • TGF-
 
 
 
Introduction
 
The process of TCR generation, that is based on random
rearrangements, as well as the promiscuity of the resulting
receptor expressed by mature T cells requires central and
peripheral mechanisms of tolerance induction (1). CD25
 
 
 
T regulatory (Treg) cells play a central role in the mainte-
nance of peripheral tolerance as the depletion of these
cells in a murine adoptive transfer model leads to various
autoimmune diseases (2, 3). These CD4
 
 
 
 T cells express
CD25 but do not or only marginally proliferate after
polyclonal or antigen-specific activation. However, al-
though they seem to be immunologically inert, activated
CD25
 
 
 
 Treg cells strongly suppress the proliferation of
coactivated conventional CD4
 
 
 
CD25
 
  
 
T cells in vitro (4,
5). We and others characterized a human equivalent of
murine CD25
 
 
 
 Treg cells that has comparable properties
and can be isolated from human peripheral blood (6–8).
The suppressive capacity of these human CD25
 
 
 
 Treg
cells depends on direct cell–cell contact but the mecha-
nism of suppression is largely unknown. Several studies
implied that signaling through CTLA-4 might be respon-
sible for the inhibitory potency of CD25
 
 
 
 Treg cells,
whereas others could not confirm this finding (2). Studies
using a murine IBD model suggest that TGF-
 
 
 
 and IL-10
are potent mediators of suppression (9, 10). However,
neither anti–IL-10 nor anti–TGF-
 
 
 
 antibodies could ab-
rogate the suppressive capacity of human CD25
 
 
 
 Treg
cells in vitro (6). On the other hand, it was shown that
blocking anti–TGF-
 
 
 
 antibodies abrogated suppressor ac-
tivity in vivo (9, 11, 12). Hence, there are a lot of con-
flicting and contradictory findings regarding the suppressive
mechanisms of CD25
 
 
 
 Treg cells. Herein we demon-
strate that coculture of human CD25
 
 
 
 Treg cells with
CD25
 
 
 
CD4
 
 
 
 T cells results in the development of an addi-
tional CD4
 
 
 
 T suppressor cell population. These induced
CD4
 
 
 
 Treg cells emerge from the CD25
 
 
 
CD4
 
 
 
 T cell
population and suppress the proliferation of freshly iso-
lated conventional CD4
 
 
 
 T cells. This process is partially
mediated by soluble TGF-
 
 
 
.
 
Materials and Methods
 
Culture Medium.
 
X-VIVO-15 supplemented with 1% autol-
ogous plasma was used for culture of dendritic cells (DCs) and
without plasma for culture of T cells (BioWhittaker).
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Cytokines.
 
All cytokines used in this study were recombinant
human proteins. Final concentrations: 800 U/ml GM-CSF
(Leukomax), IL-4, 1,000 U/ml IL-6 (Strathmann Biotech
GmbH), IL-1
 
 
 
, 10 ng/ml TNF-
 
 
 
 (Strathmann), and PGE
 
2
 
(Minprostin; Pharmacia-Upjohn) 1 
 
 
 
g/ml. The DCs were gen-
erated from buffy coats of healthy volunteers as described previ-
ously (13). For preactivation of T cells: IL-2 (Proleukin; Chiron)
10 U/ml.
 
Antibodies.
 
These mAbs were used for the staining of
MACS
 
®
 
-sorted T cells: FITC- or PE-conjugated CD3, CD4,
CD25, CTLA-4, anti–HLA-A,B,C, and FITC- and PE-conju-
gated mouse IgG (Beckman Coulter and Immunotech). These
mAbs were used for the staining of membrane-bound TGF-
 
 
 
:
LAP (biotinylated mAb, R&D Systems, used according to the
manufacturer’s instructions) detected by streptavidin-Cy5 (Di-
anova). The anti–TGF-
 
 
 
 (R&D Systems, used according to the
manufacturer’s instructions) and anti–IL-10 mAb (JES-19F1.1.1;
American Type Culture Collection (ATCC), blocking capacity
tested in proliferation assays using IL-10 receptor transfected Baf3
cells) were used for blocking experiments (14). For sorting of
preactivated HLA-A2–positive conventional CD4
 
 
 
 T cells, puri-
fied anti–HLA-A2–positive-specific mAb (BB7.2; ATCC) and
anti–mouse IgG microbeads (Miltenyi Biotec) were used. Labeled
T cells were analyzed by flow cytometry (FACScalibur™ and
CELLQuest™; Becton Dickinson). Necrosis versus apoptosis
were determined by propidium iodide and annexin-V staining
according to the manufacturer’s instructions (BD PharMingen).
 
Isolation and Stimulation of T Cell Populations.
 
Conventional
CD4
 
 
 
 Th cells and CD4
 
 
 
CD25
 
 
 
 regulatory T cells were isolated
from buffy coats of healthy volunteers as described previously (6).
Briefly, CD4-MACS
 
®
 
-Multisort-Beads (Miltenyi Biotec) were
used for isolation of CD4
 
 
 
 T cells. After detaching, cells were
washed and CD4
 
 
 
CD25
 
 
 
 T cells were positively selected
according to the instructions of the manufacturer using CD25
microbeads. For some experiments, CD4
 
 
 
CD25
 
 
 
 T cells and
conventional CD4
 
 
 
 T cells were preactivated with 0.5 
 
 
 
g/ml
anti-CD3 mAb at 37
 
 
 
C for 20 h in the presence of 10 U/ml IL-2.
Aliquots of the cultures were used for proliferation assays per-
formed in X-VIVO-15 and in the presence of different numbers
of allogeneic DCs or anti-CD3/CD28 stimulation in 96-well
plates. T cell proliferation was measured after 3–4 d of incubation
and an additional 16-h pulse with 
 
3
 
[H]Tdr (37 kBq/well) using a
liquid scintillation counter.
 
Isolation of Precultured CD4
 
 
 
 T Cells.
 
10
 
6
 
 freshly isolated
HLA-A2-negative CD4
 
 
 
 T cells and 10
 
6
 
 HLA-A2-positive
CD25
 
 
 
 Treg from a different donor were coactivated with anti-
CD3 (1 
 
 
 
g/ml) and anti-CD28 (2 
 
 
 
g/ml) mAb. After 6 d of
coculture the CD25
 
 
 
 Treg cells were stained with a HLA-A2-
specific mAb and depleted from the anergized CD4
 
 
 
 T cells us-
ing anti–mouse IgG microbeads (purity 
 
 
 
95%). The anergized
CD4
 
 
 
 T cells were restimulated with anti-CD3/CD28 mAb as
described previously. 24–72 h after restimulation aliquots were
used for detection of TGF-
 
 
 
 by ELISA (DRG-Instruments, de-
tection limit of biologically active TGF-
 
 
 
: 4.7 pg/ml).
 
Transwell Experiments.
 
Transwell experiments were done in
24-well plates as described previously (14). Briefly, 10
 
6
 
 CD4
 
 
 
conventional T cells or CD4
 
 
 
CD25
 
 
 
 T cells were stimulated
with anti-CD3 (1 
 
 
 
g/ml) and anti-CD28 (2 
 
 
 
g/ml) in 1.5 ml.
Additionally, 10
 
6
 
 CD4
 
 
 
CD25
 
 
 
 T cells or precultured CD4
 
 
 
 T
cells (Thsup) were either directly added to cultures of activated
conventional CD4
 
 
 
 T cells or were placed in transwell chambers
(Millicell, 0.4 
 
 
 
m; Millipore) in the same well. After 3 d of cul-
ture, activated T cells (200 
 
 
 
l per well) were transferred to 96-
well plates in triplicates. Proliferation was measured after an addi-
tional 16-h pulse with 
 
3
 
[H]Tdr using a liquid scintillation
counter.
 
Fixation of Freshly Isolated and Preactivated T Cells.
 
For some
experiments, conventional CD4
 
 
 
 T helper cells and CD25
 
 
 
Treg were fixed with 1% paraformaldehyde for 10 min in PBS,
either directly after isolation or 20 h after preactivation with 0.5
 
 
 
g/ml anti-CD3 mAb and 10 U/ml IL-2. Additionally, CD25
 
 
 
Treg were preactivated in the presence of 10 
 
 
 
g/ml cyclohexi-
mide or 1 
 
 
 
g/ml monensin. These concentrations of cyclo-
heximide and monensin showed no toxic effects but blocked the
upregulation of CTLA-4 on CD25
 
 
 
 Treg and CD25 on con-
ventional CD4
 
 
 
 T cells during preactivation (unpublished data).
Fixed cells were washed intensively with RPMI 1640 plus 10%
FCS and used for coculture with freshly isolated CD4
 
 
 
 T cells in
proliferation assays.
 
Results and Discussion
 
CD25
 
  
 
conventional CD4
 
 
 
 T cells and CD25
 
 
 
 Treg
cells were isolated from buffy coats of healthy volunteers as
described previously (6). Freshly isolated, CD25
 
 
 
 Treg
cells showed a fourfold increased expression of membrane-
bound TGF-
 
 
 
 as compared with conventional CD4
 
 
 
 Th
cells (Fig. 1 A). However, polyclonal activation using anti-
CD3 in combination with anti-CD28 antibodies resulted
in an upregulated surface expression of TGF-
 
 
 
 on conven-
tional CD4
 
 
 
 T cells, whereas TGF-
 
 
 
 on CD25
 
  Treg cells
was downregulated. Both populations, CD25  Treg cells
and conventional CD4  Th cells, either resting or acti-
vated, showed no significant production of biologically ac-
tive soluble TGF-  (see Fig. 4 C).
To analyze the potential inhibitory effect of membrane-
bound TGF-  on the surface of freshly isolated human
CD25  Treg cells, as postulated for murine CD25  Treg
cells (15), we stimulated freshly isolated CD4  Th cells in
coculture with human CD25  Treg cells and in the pres-
ence or absence of blocking antibodies against TGF- . As
shown in Fig. 1 B, the presence of anti–TGF-  antibodies
could not reverse the cell contact–dependent inhibitory ef-
fect of the CD25  Treg population on the proliferation of
CD4  Th cells, neither upon allogeneic nor polyclonal
stimulation of Th cells. Thus, these data indicate that
membrane-bound TGF-  is not responsible for the sup-
pressive effects of freshly isolated human CD25  Treg
cells. In addition, the fact that highly proliferative CD4 
Th cells express the same amounts of TGF-  as highly
suppressive CD25  Treg cells (Fig. 1 A) also strongly ar-
gues against the assumption that membrane-bound TGF- 
is responsible for the suppressive capacity of human
CD25  Treg cells.
To analyze the suppressive mechanism in more detail,
we stimulated CD4  T cells in the presence of fixed
CD25  Treg cells. In coculture experiments, freshly iso-
lated human CD25  Treg cells inhibited the proliferation
and cytokine production of coactivated conventional
CD4  T cells in a dose-dependent manner. If CD25 
Treg cells were fixed directly after isolation, no suppres-
sive activity could be detected (Fig. 2 A). However, if257 Jonuleit et al. Brief Definitive Report
CD25  Treg cells were preactivated overnight with anti-
CD3 antibodies (0.5  g/ml) and 10 U/ml IL-2 before fix-
ation, they showed a comparable suppressive capacity for
CD4  T cells as unfixed CD25  Treg cells. In contrast,
Treg-depleted and activated conventional CD4  T helper
cells did not exert any suppressive activity, although such
cells express comparable amounts of TGF-  (Fig. 1 A).
These data suggest that the inhibitory function of human
CD25  Treg cells is activation dependent. Additional ex-
periments revealed that the induction of suppressor activ-
ity requires protein synthesis as it can be inhibited by the
presence of cycloheximide or monensin (Fig. 2 B). How-
ever, once activated, the suppressive activity of human
CD25  Treg cells is fixation-resistant (Fig. 2 A). These
data also strongly corroborate our findings that the inhibi-
Figure 1. The suppressive activity of human CD25  Treg cells is inde-
pendent from membrane-bound TGF- . CD4  and CD4 CD25  T
cells were isolated from buffy coats of healthy volunteers by positive se-
lection using paramagnetic beads. (A) Surface expression of TGF-  by
freshly isolated CD4  T cells and CD25  Treg cells in comparison to the
same T cell populations preactivated for 48 h with anti-CD3 (OKT3, 1
 g/ml) and anti-CD28 mAb (CD28.2, 2  g/ml). The figure shows the
expression of TGF-  (LAP-biotinylated) detected by streptavidin-Cy5
and CD4 (RPAT4-FITC). (B) CD4  T cells (105 cells per well) or
CD25  Treg cells (105 cells per well), alone or in coculture (1:1), were
stimulated with allogeneic mature DC (104 cells per well) or by anti-CD3
(1  g/ml) plus anti-CD28 mAb (2  g/ml). Neutralizing anti-TGF- 
mAb (10  g/ml) was added to the cocultured cells as indicated. 3[H]Tdr
was added after 3 (polyclonal stimulation) or 4 d (allogeneic MLR) of cul-
ture for the final 16 h.
Figure 2. The suppressive activity of activated CD25  Treg cells is fix-
ation-resistant but the activation is sensitive to treatment with monensin
or cycloheximide. (A) Freshly isolated CD4  T cells (105 cells per well)
and CD25  Treg cells (105 cells per well) or a combination of both (1:1)
were activated with anti-CD3 (1  g/ml) and anti-CD28 mAb (2  g/ml).
In addition, CD4  T cells were coactivated with CD25  Treg cells or
conventional CD4  T cells that were immediately fixed after isolation
(1% paraformaldehyde, 10 min) or were fixed after preactivation with 0.5
 g anti-CD3 mAb plus 10 U/ml IL-2 for 20 h (black bars). (B) CD4  T
cells were coactivated either with preactivated and fixed CD25  Treg
cells or with CD25  Treg cells treated with monensin (1  g/ml) or cy-
cloheximide (10  g/ml) during preactivation before fixation. 3[H]Tdr
was added after 3 d of culture for the final 16 h.258 Human Regulatory T Cells Convey Suppressor Activity
tory function of human CD25  Treg cells is independent
of soluble mediators (6). Furthermore, the activation of
suppressor function of human CD25  Treg is also inde-
pendent of costimulation, since the addition of mature
DCs or soluble anti-CD28 antibodies during overnight
preactivation with anti-CD3 antibodies did not alter/en-
hance the functional activities of human CD25  Treg cells
(unpublished data).
We and others could not detect any influence of TGF- 
on the cell contact–mediated inhibitory function of
CD25  Treg cells in vitro (2, 6), whereas several groups
demonstrated that neutralizing antibodies against TGF- 
abrogated the suppressive function of murine CD25  Treg
cells in vivo (9, 15). One possible explanation for this dis-
crepancy could be that CD25  Treg cells exert an addi-
tional suppressive mechanism that is presumably also in-
volved in the phenomena of bystander suppression or
infectious tolerance (10, 16) but is not directly mediated
by the CD25  Treg cells themselves. Consequently, we
analyzed the functional properties of the anergized con-
ventional CD4  Th cells after coculture with human
CD25  Treg cells. To distinguish both T cell populations,
HLA-mismatched CD25  Treg cells were used and de-
pleted of the anergized CD4  T cells after coculture with
the aid of HLA-specific mAbs as illustrated in Fig. 3 A.
Coculture of HLA-mismatched conventional CD4  T
cells served as a control. As shown in Fig. 3 B, the purified
CD4  T cells, anergized by CD25  Treg cells, revealed a
strong suppressive activity for conventional CD4  Th cells
that was comparable to the inhibitory capacity of CD25 
Treg cells. Thus, human CD25  Treg cells, in a cell con-
tact–dependent fashion, suppress the proliferation of con-
ventional CD4  T cells and simultaneously induce sup-
pressive activity in these CD4  Th cells (Fig. 3 B). In
contrast, conventional CD4  T cells preactivated in the
presence of HLA-mismatched conventional CD4  T cells
showed no suppressive activity for freshly isolated Th cells
(Fig. 3 B, lowest bar).
To elucidate the mechanism of this conveyed suppres-
sive activity, we analyzed the properties of the anergized
CD4  T cells (subsequently termed Thsup) in comparison
to the original CD25  Treg population in transwell stimu-
lations. The semipermeable transwell membrane prevents
direct cell–cell contact between the responsive Th cell
population and the suppressor T cells. As shown recently,
the physical separation by the transwell membrane abro-
gated the cell contact–dependent suppression of CD4  Th
cells by CD25  Treg cells (6). In contrast, the conveyed
suppressor activity of Thsup cells could not be abrogated by
the semipermeable membrane (Fig. 4 A). However, fixa-
tion of such Thsup cells completely abrogated their suppres-
sor function while it could not inhibit the suppressive
properties of activated CD25  Treg cells (Fig. 4 B). These
data strongly support our primary finding that the induced
secondary suppressor activity of Thsup cells is cell contact
independent. In addition, these results were further con-
firmed by the fact, that the suppressive activity of Thsup
cells could be partially abrogated upon the addition of neu-
tralizing anti–TGF-  antibodies (Fig. 4 A), whereas neu-
tralizing anti–IL-10 antibodies showed no effect (data not
shown). These data strongly suggest that the suppressive ac-
tivity of Thsup cells is mediated partially by biologically ac-
tive TGF- . Therefore, the production of TGF-  was
assessed by using an ELISA that specifically detects biologi-
cally active material. As shown in Fig. 4 C, Thsup cells pro-
duce biologically active TGF-  immediately after poly-
clonal stimulation. In contrast, neither conventional CD4 
Th cells nor CD25  Treg cells, alone or in coculture, pro-
duced detectable amounts of TGF- . This finding again
strongly supports our thesis that resident human CD25 
Treg cells convey a suppressor function to conventional
CD4  Th cells that is completely cell contact independent
and mediated mainly by TGF- .
In summary, our findings help to explain several con-
flicting and contradictory results published previously. In
accordance with published data on the properties of resi-
dent murine and human CD25  Treg in vitro (2, 6, 8),
we show that the primary functional activity of CD25 
Treg is strictly activation- and cell contact–dependent and
independent of soluble mediators. Moreover, our data
clearly indicate that classical human CD25  Treg cells
can, in a cell contact–dependent manner, direct the dif-
ferentiation of conventional CD4  Th cells toward an ad-
ditional population of regulatory T cells (Thsup). Both
Figure 3. CD25  Treg cells convey a suppressive activity to conven-
tional CD4  Th cells. (A) Cocultured HLA-A2-positive CD25  Treg
cells (106/ml) and HLA-mismatched CD4  T cells (106/ml, HLA-A2-
negative) were primarily activated by anti-CD3 (1  g/ml) and anti-
CD28 mAb (2  g/ml). As a control HLA-A2-negative CD4  T cells
were also coactivated with HLA-A2-positive CD4  T cells. After 6 d of
culture the HLA-A2-positive CD25  Treg cells and HLA-A2-positive
CD4  T cells were depleted from HLA-A2-negative CD4  T cells using
a HLA-specific mAb (BB7.2) and paramagnetic microbeads (purity of
precultured CD4  T cells  95%). (B) The remaining precultured CD4 
T cells (105 cells per well) were  -irradiated (3,000 rad) and secondarily
stimulated with freshly isolated CD4  responder T cells (105 cells per
well, 1:1) using anti-CD3 and anti-CD28 mAb. In addition, freshly iso-
lated CD25  Treg cells were used as a control population. 3[H]Tdr was
added after 3 d of culture for the final 16 h.259 Jonuleit et al. Brief Definitive Report
regulatory T cell populations can inhibit Th cell prolifera-
tion through distinct suppressor mechanisms (cell con-
tact–dependent versus soluble mediators). Thus, these re-
sults imply that human CD25  Treg cells can amplify
their suppressive capacity through the recruitment of an
additional population of suppressor T cells that exert a
distinct but complementary suppressor mechanism. Data
from murine in vivo studies suggest that the suppressive
properties of CD25  Treg cells are mediated via soluble
mediators such as TGF-  (2). In contrast, in vitro studies
clearly revealed that murine and human CD25  Treg
cells inhibit T cell proliferation via cell contact and inde-
pendent from soluble factors (6, 8). These apparently dis-
cordant results could be reconciled by the assumption that
in vitro a local cell contact–dependent mechanism is suffi-
cient to inhibit the proliferation of the responding T cell
population. However, in vivo, e.g., in the murine model
of IBD (9), additional soluble suppressive mediators such
as TGF- , derived from anergized CD4  Th cells, are
important for the systemic control of autoreactive T ef-
fector cells (Fig. 5). Finally, the regulation of immune re-
sponses that includes bystander suppression and infectious
tolerance (10, 16) obviously requires a transfer of toleriz-
ing potencies from resident or induced CD25  Treg cells
to another T cell population with a different antigen
specificity. Hence, we would like to speculate that the
spreading of suppression from human CD25  Treg cells
to conventional CD4  Th cells is one of the fundamental
mechanisms that is involved in the induction or mainte-
nance of peripheral tolerance.
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Figure 4. The suppressive activity of CD251 Treg-induced CD4  Th
cells is partially mediated by soluble TGF- . (A) 106 Freshly isolated
CD4  T cells were activated alone or in coculture with 106 CD25  Treg
cells or 106 Thsup cells by anti-CD3 (1  g/ml) and anti-CD28 mAb (2  g/
ml). Transwell chambers were used to prevent the direct cell contact be-
tween the T cell populations, neutralizing mAb against TGF-  were used
at 10  g/ml. After 3 d, aliquots from all approaches were transferred to
96-well microplates and 3[H]Tdr was added for the final 16 h. (B) Freshly
isolated CD4  T cells were activated alone or in coculture with freshly
isolated CD25  Treg cells. In addition, such CD4  T cells were coacti-
vated with CD25  Treg cells or Thsup cells that had been fixed after preac-
tivation with 0.5  g/ml anti-CD3 mAb plus 10 U/ml IL-2 for 20 h (1:1).
3[H]Tdr (1  Ci per well) was added after 3 d of culture for the final 16 h.
(C) Freshly isolated CD4  T cells and CD25  Treg cells or a mixture of
both were activated with anti-CD3 (1  g/ml) and anti-CD28 mAb (2
 g/ml) for 3 d. Thsup cells were also activated under the same conditions
for 20 and 96 h, respectively. The content of biologically active TGF-  of
the resulting supernatants was assessed by a TGF- –specific ELISA.
Figure 5. Model of T effector cell regulation. We propose the follow-
ing model of immunoregulation by CD25  Treg in vivo: resident or in-
duced CD25  Treg suppress the activation of conventional Th cells.
This is a cell contact–dependent local inhibitory effect. The induced
secondary T suppressor cells (Thsup) produce inhibitory mediators such
as biologically active TGF-  which itself inhibits the activation of T
effector cells. This secondary systemic suppressive effect is cell contact
independent.260 Human Regulatory T Cells Convey Suppressor Activity
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